MtETC in M1 macrophage polarization
Role of mtETC in M1 macrophage polarization. LPS, IFN-γ and/or TNF-α (not shown here) stimulate reprogramming of macrophages toward the pro-inflammatory phenotype. During metabolic reprogramming, the TCA cycle is disrupted at two points (at the steps of α-ketoglutarate and malate conversion) resulting in the accumulation of citrate and succinate, disrupting the feeding of electrons to the mtETC. The interruption activates the “Warburg effect” and shifts the cellular metabolism towards aerobic glycolysis to meet the energy demands. This results in the upregulation of glycolytic enzymes, and lactate production. M1 macrophages upregulate PKM2, catalyzing in the conversion of PEP into pyruvate and promoting glycolysis. Succinate synthesis is promoted in M1 macrophages via the channeling of glutamine into the TCA cycle through GABA shunt and through anaplerosis. Oxidation of succinate to fumarate via C II during low OXPHOS conditions results in the transfer of electrons in the opposite direction toward C I, leading to RET that induces mtROS production, which activates HIF-1α. HIF-1α, a signaling molecule characteristic of the M1 phenotype, drives the production of pro-inflammatory cytokines, such as IL-1β. In M1 macrophages, oxidation of G6P is enhanced due to an increase in oxidative PPP which generates NADPH that is required for NOX-induced ROS (shown by broken black arrow), synthesis of fatty acids, and anti-oxidant defense mechanisms, and ribulose-5P that is required for nucleotide biosynthesis, and this occurs due to suppressed activity of CARKL. M1 macrophages show upregulation in the PDK1 enzyme, a regulatory enzyme that phosphorylates PDH that catalyses the conversion of pyruvate to acetyl coA. Pyruvate-derived acetyl CoA (shown by broken black arrow) enters into the TCA cycle that generates NADH which fuels mtETC. Reduction in IDH1 levels led to an increase in the synthesis of antimicrobial molecule i.e., itaconic acid (or Itaconate) via IRG1 from decarboxylation of aconitate. However, increased production of itaconate inhibits SDH activity. Furthermore, citrate is exported from the mitochondria via CIC, and broken down into oxaloacetate and acetyl CoA via ACLY. Acetyl CoA can be used as a substrate for fatty acid synthesis. Oxaloacetate is metabolized to pyruvate accompanied by NADPH and NO production. In M1 macrophages, iNOS activity is upregulated, resulting in the catabolism of arginine to citrulline and NO (shown by broken black arrow), the latter playing a crucial antimicrobial role in M1 macrophages. Citrulline is metabolized along with aspartate to generate argininosuccinate via ASS, which is further catalyzed into arginine and fumarate. Further, NO-induced nitrosylation of Fe–S proteins in C I, and C IV results in their inactivation resulting in low OXPHOS. The black solid arrows represent the movement of substrates, the broken blue arrows represent the activation of enzymatic and signaling pathways in M1 macrophages, and the broken red line represent the inhibition of the enzymes/pathways in M1 macrophages. Abbreviations used are: GLUT1, glucose transporter 1; CARKL, carbohydrate kinase-like protein; PPP, pentose phosphate pathway; G6P, glucose-6-phosphate; PKM2, pyruvate kinase M2; PDH, pyruvate dehydrogenase; PDK1, pyruvate dehydrogenase kinase 1; CIC, citrate carrier; IRG1, immune responsive gene 1; ASS, argininosuccinate synthase; GABA, γ-amino butyric acid; NOX, NADPH oxidase; mtROS, mitochondrial ROS; CIC, citrate carrier; ACLY, ATP-citrate lyase; NO, nitric oxide; iNOS, inducible NO synthase; ASS, argininosuccinate synthase; RET, reverse electron transfer; PEP, phosphoenolpyruvate. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Publication
Mitochondrial electron transport chain in macrophage reprogramming: Potential role in antibacterial immune response (2024) Manmohan Kumar, et al. Curr Res Immunol. 2024;5(NA). Figure: F9.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR1 | 7096 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR2 | 7097 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR3 | 7098 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR4 | 7099 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR5 | 7100 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR6 | 10333 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR7 | 51284 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR8 | 51311 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR9 | 54106 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR10 | 81793 |
| Homo sapiens | Primates | GLUT1 | GLUT1 | ncbigene_synonym | SLC2A1 | 6513 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | ncbigene_synonym | HK1 | 3098 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | GCK | 2645 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | HK2 | 3099 |
| Homo sapiens | Primates | Hexokinase | HEXOKINASE | famplex_relations | HK3 | 3101 |
| Homo sapiens | Primates | CARKL | CARKL | ncbigene_synonym | SHPK | 23729 |
| Homo sapiens | Primates | PKM2 | PKM2 | ncbigene_synonym | PKM | 5315 |
| Homo sapiens | Primates | PKM2 | PKM2 | famplex_relations | PKLR | 5313 |
| Homo sapiens | Primates | PDH | PDH | ncbigene_synonym | PDP1 | 54704 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | DLAT | 1737 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | DLD | 1738 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHA1 | 5160 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHA2 | 5161 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHB | 5162 |
| Homo sapiens | Primates | PDH | PDH | famplex_relations | PDHX | 8050 |
| Homo sapiens | Primates | NADPH | NADPH | ncbigene_synonym | DECR1 | 1666 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_symbol | PDK1 | 5163 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_synonym | PDPK1 | 5170 |
| Homo sapiens | Primates | ACLY | ACLY | ncbigene_symbol | ACLY | 47 |
| Homo sapiens | Primates | INOS | INOS | ncbigene_synonym | NOS2 | 4843 |
| Homo sapiens | Primates | INOS | INOS | ncbigene_synonym | ISYNA1 | 51477 |
| Homo sapiens | Primates | CIC | CIC | ncbigene_symbol | CIC | 23152 |
| Homo sapiens | Primates | CIC | CIC | ncbigene_synonym | SLC25A1 | 6576 |
| Homo sapiens | Primates | IRG1 | IRG1 | ncbigene_synonym | ACOD1 | 730249 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1A | 3552 |
| Homo sapiens | Primates | IL-1ẞ | IL1 | ncbigene_synonym | IL1B | 3553 |
| Homo sapiens | Primates | HIF-1a | HIF-1A | ncbigene_synonym | HIF1A | 3091 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | RET | RET | ncbigene_symbol | RET | 5979 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| Glucose | Glucose | aldehydo-D-glucose | chebi:42758 | |
| PPP | PPP | L-prolyl-L-prolyl-L-proline | chebi:73647 | |
| Lactate | lactate | lactate | chebi:24996 | |
| Pyruvate | pyruvate | pyruvate | chebi:15361 | |
| Acetyl | acetyl | 1-oxoethanido | chebi:40574 | |
| CoA | CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate} | chebi:57287 | |
| Nucleotides | nucleotides | chebi:36976 | ||
| NADPH | NADPH | 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} | chebi:57783 | |
| Fatty acid | Fatty acid | fatty acids | chebi:35366 | |
| Oxaloacetate | oxaloacetate | 2-oxobutanedioate | chebi:16452 | |
| NOX | NOX | 3-[(2S)-1-methyl-1-oxidopyrrolidin-2-yl]pyridine | chebi:142659 | |
| NADP+ | NADP+ | 2'-O-phosphonoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:18009 | |
| ROS | ROS | chebi:26523 | ||
| Citrulline | Citrulline | N(5)-carbamoyl-L-ornithine | chebi:16349 | |
| Citrate | citrate | chebi:133748 | ||
| Citrate | citrate | chebi:133748 | ||
| Oxaloacetate | oxaloacetate | 2-oxobutanedioate | chebi:16452 | |
| Arginine | arginine | L-arginine | chebi:16467 | |
| Malate | Malate | (2S)-2-hydroxybutanedioic acid | chebi:30797 | |
| Itaconate | itaconate | itaconate | chebi:17240 | |
| acid | acid | acid | chebi:37527 | |
| Itaconate | itaconate | itaconate | chebi:17240 | |
| Fumarate | fumarate | fumarate | chebi:29806 | |
| GABA | GABA | 4-aminobutanoic acid | chebi:16865 | |
| Succinate | succinate | succinate | chebi:30031 | |
| Glutamine | GLUTAMINE | L-glutamine | chebi:18050 | |
| Succinyl | succinyl | butanedioyl | chebi:37952 | |
| CoA | CoA | 3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate} | chebi:57287 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|